Searched over 200M research papers
10 papers analyzed
Some studies suggest that type 2 diabetes can be reversed through bariatric surgery, low-calorie diets, or carbohydrate restriction, while other studies highlight promising treatments involving peptides, proteins, adipokines, fibroblast growth factors, glycyrrhizic acid, and natural products like galegine, flavonoids, and polyphenols.
20 papers analyzed
Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by insulin resistance and hyperglycemia. Traditionally, it has been considered incurable, but recent research suggests that reversal or significant remission is possible through various methods . This article explores the current evidence and potential pathways for curing T2D.
Bariatric surgery has emerged as a significant method for reversing T2D. This surgical intervention, which includes procedures like gastric bypass and sleeve gastrectomy, has been recommended by international diabetes consensus groups since 2016. The surgery induces substantial weight loss and alters gut hormones, leading to improved insulin sensitivity and glycemic control. However, it is important to note that while effective, bariatric surgery is invasive and may not be suitable for all patients.
Low-calorie diets (LCD) have shown promise in reversing T2D by significantly reducing caloric intake, which leads to weight loss and improved insulin sensitivity. Both the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) support the short-term use of LCD for weight loss, although their guidelines focus on treatment rather than reversal.
Carbohydrate restriction (LC) is another dietary approach that has gained traction for its potential to reverse T2D. By limiting carbohydrate intake, this diet helps in reducing blood glucose levels and improving insulin sensitivity. The ADA and EASD now recommend LC eating patterns as part of diabetes management.
Recent advancements in pharmaceutical treatments for T2D include the development of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors. These drugs offer better glycemic control and reduce complications associated with T2D . Additionally, novel targets such as adiponectin and fibroblast growth factor (FGF) 21 are being explored for their potential benefits in managing T2D.
Natural products and traditional Chinese medicine (TCM) are also being investigated for their potential in managing and treating T2D. Glycyrrhizic acid (GL), derived from licorice, has shown promise in controlling blood glucose levels and managing T2D complications. Other natural products, such as berberine, curcumin, and resveratrol, have been identified for their antidiabetic properties and are considered safer alternatives to conventional pharmacological therapies .
While a definitive cure for type 2 diabetes remains elusive, significant progress has been made in reversing or achieving remission of the disease through various methods. Bariatric surgery, low-calorie diets, and carbohydrate restriction have shown substantial promise in reversing T2D. Additionally, advancements in pharmaceutical treatments and natural therapeutic products offer new avenues for managing and potentially curing T2D. Continued research and education are essential for healthcare providers to effectively counsel patients on these emerging options.
Most relevant research papers on this topic